Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Recludix Pharma hired Paul Smith as senior vice president, biology. Previously, he worked at Connect Biopharma as vice president, discovery biology, and before that, he was at Incyte and Novartis.
But all work and no play can make for a dull clinical development executive. So in his spare time, Smith enjoys football — or soccer, to you Yanks. “I like playing it – badly. It’s a social, informal thing. But in the past, I’d organize games among people at companies. I’m an enthusiastic defender, who has to keep up with the younger guys. So I have to play the game with more intelligence. I’m from the U.K. and my team is Arsenal. So my mood goes up and down, depending on how well the team is doing. Every weekend, I get up early due to the time difference to watch a match. It’s a borderline obsession.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect